Treanda Clinical Trials Treanda RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma
Condition:   Hodgkin Lymphoma Intervention:   Drug: Nivolumab Sponsor:   National Research Center for Hematology, Russia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2022 Category: Research Source Type: clinical trials